- ISIN
- US2854091087
- CUSIP
- 285409108
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Aug 13, 2010
Highlights
- Market Cap
- $308.29M
- Enterprise Value
- $291.31M
- EPS (TTM)
- $1.16
- PE Ratio
- 30.64
- PEG Ratio
- 0.84
- Total Revenue (TTM)
- $71.75M
- Gross Profit (TTM)
- $56.28M
- EBITDA (TTM)
- $14.10M
- Year Range
- $17.73 - $40.00
- Target Price
- $38.00
- ROA (TTM)
- 16.99%
- ROE (TTM)
- 20.55%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ELMD Performance Chart
Electromed, Inc. (ELMD) is up 22.4% since the beginning of the year. At $36 per share, ELMD is trading 10.9% below its 52-week high of $40. Investors who bought $1,000 worth of ELMD shares 5 years ago would now be looking at an investment worth $3,259.
Loading charts...
Returns By Period
Electromed, Inc. (ELMD) has returned 22.42% so far this year and 74.07% over the past 12 months. Looking at the last ten years, ELMD has achieved an annualized return of 23.08%, outperforming the S&P 500 Index benchmark, which averaged 13.66% per year.
Electromed, Inc.
- 1D
- -2.54%
- 1M
- 39.48%
- YTD
- 22.42%
- 6M
- 27.55%
- 1Y
- 74.07%
- 3Y*
- 44.52%
- 5Y*
- 26.65%
- 10Y*
- 23.08%
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
ELMD Monthly Returns History
Based on dividend-adjusted daily data since Aug 13, 2010, ELMD's average daily return is +0.14%, while the average monthly return is +3.08%. At this rate, an investment would double in approximately 1.9 years.
Historically, 51% of months were positive and 49% were negative. The best month was Dec 2013 with a return of +208.6%, while the worst month was Jan 2014 at -50.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 11 months.
On a daily basis, ELMD closed higher 46% of trading days. The best single day was Dec 30, 2013 with a return of +106.9%, while the worst single day was Nov 8, 2017 at -18.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.58% | -20.66% | -1.22% | 9.82% | 46.71% | -5.49% | 22.42% | ||||||
| 2025 | 16.41% | -21.40% | -11.76% | -3.48% | -12.29% | 8.86% | -17.19% | 35.80% | -0.73% | -2.00% | 11.26% | 8.78% | -1.46% |
| 2024 | -7.88% | 51.24% | 6.25% | 7.68% | -15.93% | 2.80% | 4.06% | 9.65% | 25.19% | 8.29% | 32.39% | -4.00% | 170.85% |
| 2023 | 2.86% | 23.49% | -21.95% | 5.29% | 6.76% | -8.38% | -4.76% | -2.75% | 4.74% | 1.35% | -2.37% | 6.13% | 4.00% |
| 2022 | -0.38% | -5.33% | 1.47% | 1.85% | -11.05% | -14.46% | -6.43% | 7.54% | 5.67% | 3.61% | -5.93% | 5.01% | -19.31% |
| 2021 | 1.33% | 6.24% | -0.19% | -7.31% | 0.92% | 14.50% | 3.99% | 5.88% | -12.95% | 1.48% | 9.47% | 8.15% | 32.52% |
Benchmark Metrics
Electromed, Inc. has an annualized alpha of 29.67%, beta of 0.60, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since August 16, 2010.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (74.34%) than losses (51.78%) - typical of diversified or defensive assets.
- Beta of 0.60 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 29.67%
- Beta
- 0.60
- R²
- 0.02
- Upside Capture
- 74.34%
- Downside Capture
- 51.78%
Return for Risk
Risk / Return Rank
ELMD ranks 80 for risk / return — in the top 80% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Electromed, Inc. (ELMD) and compare them to S&P 500 Index.
| ELMD | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.41 | 2.24 | -0.83 |
Sortino ratioReturn per unit of downside risk | 2.27 | 3.07 | -0.80 |
Omega ratioGain probability vs. loss probability | 1.29 | 1.41 | -0.11 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | 2.93 | +0.27 |
Martin ratioReturn relative to average drawdown | 6.48 | 13.52 | -7.04 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Electromed, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Electromed, Inc. was 78.65%, occurring on Sep 16, 2013. Recovery took 617 trading sessions.
The current Electromed, Inc. drawdown is 9.26%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2013 bear market2013 | -78.65%Sep 2013 | 1y 10mo | 2y 5mo | 4y 4moOct 2011 - Feb 2016 |
2020 bear market2020 | -55.84%Nov 2020 | 2mo 24d | 3y 6mo | 3y 8moAug 2020 - May 2024 |
2025 bear market2025 | -48.86%Jul 2025 | 5mo 22d | 9mo 27d | 1y 3moJan 2025 - May 2026 |
COVID crash2020 | -45.86%Mar 2020 | 21d | 27d | 1mo 18dFeb 2020 - Apr 2020 |
2016 bear market2016 | -39.72%Nov 2016 | 2mo 11d | 7mo 14d | 9mo 25dAug 2016 - Jun 2017 |
Drawdown Indicators
| ELMD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.65% | -56.78% | -21.87% |
Max Drawdown (1Y)Largest decline over 1 year | -23.27% | -9.10% | -14.17% |
Max Drawdown (3Y)Largest decline over 3 years | -48.86% | -18.90% | -29.96% |
Max Drawdown (5Y)Largest decline over 5 years | -48.86% | -25.43% | -23.43% |
Max Drawdown (10Y)Largest decline over 10 years | -55.84% | -33.92% | -21.92% |
Current DrawdownCurrent decline from peak | -9.26% | -0.74% | -8.52% |
Average DrawdownAverage peak-to-trough decline | -33.81% | -10.72% | -23.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.47% | 1.97% | +9.50% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Electromed, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Electromed, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ELMD, comparing it with other companies in the Medical Devices industry. Currently, ELMD has a P/E ratio of 30.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ELMD compared to other companies in the Medical Devices industry. ELMD currently has a PEG ratio of 0.8. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ELMD relative to other companies in the Medical Devices industry. Currently, ELMD has a P/S ratio of 4.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ELMD in comparison with other companies in the Medical Devices industry. Currently, ELMD has a P/B value of 6.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ELMD
Add Electromed, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ELMD